1. Insulin-like growth factor (IGF) axis in cancerogenesis
   Aldona Kasprzak et al, 2017, Mutation Research/Reviews in Mutation Research CrossRef
2. Internal driving factors leading to extrahepatic manifestation of the hepatitis�C virus infection
   Zhou-Yi Wu et al, 2017, International Journal of Molecular Medicine CrossRef
3. Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis
   Jing Wang et al, 2017, Oncotarget CrossRef
4. Insulin Growth Factor-1 as a Predictor for the Progression of Hepatic Disease in Chronic Hepatitis B Virus Infection
   Amal Ahmed Mohamed et al, 2021, The Open Biomarkers Journal CrossRef
5. Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma
   Jinjin Yan et al, 2017, Oncology Letters CrossRef
6. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor
   Mona A. Abu El-Makarem et al, 2022, PLOS ONE CrossRef
7. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study
   null null et al, 2016, Tumor Biology CrossRef
8. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
   Aldona Kasprzak, 2021, International Journal of Molecular Sciences CrossRef
9. Insulin-Like Growth Factor (IGF) System in Liver Diseases
   Agnieszka Adamek et al, 2018, International Journal of Molecular Sciences CrossRef
10. Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis
    P. Wang et al, 2015, Irish Journal of Medical Science (1971 -) CrossRef